1. |
Directly observed therapy for TB recommended by US panel |
|
Inpharma Weekly,
Volume &NA;,
Issue 1131,
1998,
Page 2-2
&NA;,
Preview
|
PDF (825KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
2. |
Cocktail controversy for cancer |
|
Inpharma Weekly,
Volume &NA;,
Issue 1131,
1998,
Page 3-3
Gill Higgins,
Preview
|
PDF (723KB)
|
|
摘要:
The Italian Health Ministry recently announced that it would start clinical trials of the controversial anticancer drug cocktail developed by Professor Luigi Di Bella. The decision is a response to strong public pressure on the Italian government to reimburse the treatment following claims that it is a ‘miracle cure’. The government set up an international panel of cancer experts to advise on the trials, which were scheduled to begin last month. Dr Kate Law who is head of clinical information at the UK Cancer Research Campaign (CRC) shed more light on the subject during an interview withInpharma.
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
3. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1131,
1998,
Page 4-4
&NA;,
Preview
|
PDF (718KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
4. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1131,
1998,
Page 5-5
&NA;,
Preview
|
PDF (737KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
5. |
Insulin use and complications drive up diabetes mellitus costs |
|
Inpharma Weekly,
Volume &NA;,
Issue 1131,
1998,
Page 6-6
&NA;,
Preview
|
PDF (779KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
6. |
Leflunomide may prevent allergic sensitisation |
|
Inpharma Weekly,
Volume &NA;,
Issue 1131,
1998,
Page 7-7
&NA;,
Preview
|
PDF (700KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
7. |
Saruplasevsstreptokinaseequivalent 30-day mortality |
|
Inpharma Weekly,
Volume &NA;,
Issue 1131,
1998,
Page 8-8
&NA;,
Preview
|
PDF (729KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
8. |
Neurokinin1-receptor antagonists for postoperative nausea and vomiting? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1131,
1998,
Page 9-10
Wayne Elwood,
Preview
|
PDF (1500KB)
|
|
摘要:
Postoperative nausea and vomiting (PONV) can lead to delayed recovery time for an individual in the immediate postsurgical period, resulting in increased costs of care. While the long-term morbidity of PONV is relatively low, most patients are more concerned with how they will feel after a surgical procedure than they are about the occurrence of rare but serious complications. The introduction of selective serotonin3(5-HT3)-receptor antagonists has positively influenced the management of patients with PONV. Unfortunately, these agents are not 100% efficacious in all patients. Thus, a significant opportunity exists to extend the clinical efficacy achieved in this indication. An exciting new class of compounds, the neurokinin1(NK1)-receptor antagonists, is progressing down the R&D pipeline and it is hoped these novel agents will meet this need, delegates were told at the 72nd Clinical and Scientific Congress of the International Anaesthesia Research Society [Orlando, US; March 1998].
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
9. |
Low-dose bupivacaine + sufentanilimproving obstetric analgesia |
|
Inpharma Weekly,
Volume &NA;,
Issue 1131,
1998,
Page 10-10
&NA;,
Preview
|
PDF (727KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
10. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1131,
1998,
Page 11-11
&NA;,
Preview
|
PDF (687KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|